Charles River Laboratories (CRL) is a life sciences tools & services company in the Health Care sector. Listed on the NASDAQ, Charles River Laboratories is a component of the S&P 500 index. As of 2026-06-10, the stock is trading at $186.29.
Key Metrics & Risk
Based on 5-year historical data from Yahoo Finance (daily returns, annualized using 252 trading days).
| Metric | Value |
|---|---|
| Latest Price | $186.29 |
| Latest Date | 2026-06-10 |
| Expected Return (Annualized) | -3.49% |
| Risk / Std Dev (Annualized) | 42.77% |
| Sharpe Ratio (rf=4.5%) | -0.19 |
S&P 500 Context
- Sector: Health Care
- Sub-Industry: Life Sciences Tools & Services
- Exchange: NASDAQ
- Index: S&P 500 Component
Risk/Return Profile
The stock shows an annualized expected return of -3.49% with an annualized volatility of 42.77%. The Sharpe ratio of -0.19 (assuming 4.5% risk-free rate) indicates negative risk-adjusted returns relative to the risk-free rate.
Modern Portfolio Theory Positioning
This stock is plotted on the S&P 500 Modern Portfolio Theory chart which visualizes the risk/return trade-off across all S&P 500 components. The chart uses Sharpe ratio as the color dimension, allowing quick identification of stocks with superior risk-adjusted performance.
Fundamentals
| Metric | Value |
|---|---|
| Market Cap | 8.97B |
| Enterprise Value | 11.89B |
| Forward P/E | 15.13 |
| Price to Book | 3.05 |
| Price to Sales | 2.23 |
| EV/Revenue | 2.95 |
| EV/EBITDA | 13.37 |
| Profitability | | | Profit Margin | -4.58% | | Operating Margin | 15.92% | | ROE | -5.87% | | ROA | 4.26% |
| Growth | | | Revenue Growth | 1.2% |
| Financial Health | | | Total Revenue | 4.03B | | Total Debt | 3.06B | | Total Cash | 0.19B | | Free Cash Flow | 0.51B | | Operating Cash Flow | 0.61B |
| Price & Technical | | | 52W High | $228.88$ | | 52W Low | $143.06$ | | 50-Day Avg | $172.39$ | | 200-Day Avg | $177.2$ | | Beta | 1.45 | | Shares Outstanding | 0.05B | | Float Shares | 0.05B | | Insider Holdings | 1.0% | | Institutional Holdings | 123.42% | | Short Ratio | 4.01 | | Short % of Float | 9.34% |
| Analyst Targets | | | Target High | $265.0$ | | Target Low | $135.0$ | | Target Mean | $212.27$ | | Target Median | $220.0$ | | # of Analysts | 15 | | Recommendation | buy |
Disclaimer
This analysis is for educational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Always conduct your own research or consult a qualified financial advisor before making investment decisions.